BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 23009763)

  • 1. Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome.
    Baldini C; Gallo A; Perez P; Mosca M; Alevizos I; Bombardieri S
    Clin Exp Rheumatol; 2012; 30(5):785-90. PubMed ID: 23009763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Proteomics of Saliva in Sjögren's Syndrome.
    Katsiougiannis S; Wong DT
    Rheum Dis Clin North Am; 2016 Aug; 42(3):449-56. PubMed ID: 27431347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic diagnosis of Sjögren's syndrome.
    Giusti L; Baldini C; Bazzichi L; Bombardieri S; Lucacchini A
    Expert Rev Proteomics; 2007 Dec; 4(6):757-67. PubMed ID: 18067414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines in Sjögren's syndrome.
    Roescher N; Tak PP; Illei GG
    Oral Dis; 2009 Nov; 15(8):519-26. PubMed ID: 19519622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjögren's syndrome.
    Delaleu N; Mydel P; Kwee I; Brun JG; Jonsson MV; Jonsson R
    Arthritis Rheumatol; 2015 Apr; 67(4):1084-95. PubMed ID: 25545990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers.
    Aqrawi LA; Galtung HK; Guerreiro EM; Øvstebø R; Thiede B; Utheim TP; Chen X; Utheim ØA; Palm Ø; Skarstein K; Jensen JL
    Arthritis Res Ther; 2019 Jul; 21(1):181. PubMed ID: 31366407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for lymphotoxin in primary Sjogren's disease.
    Shen L; Suresh L; Wu J; Xuan J; Li H; Zhang C; Pankewycz O; Ambrus JL
    J Immunol; 2010 Nov; 185(10):6355-63. PubMed ID: 20952683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.
    Aqrawi LA; Galtung HK; Vestad B; Øvstebø R; Thiede B; Rusthen S; Young A; Guerreiro EM; Utheim TP; Chen X; Utheim ØA; Palm Ø; Jensen JL
    Arthritis Res Ther; 2017 Jan; 19(1):14. PubMed ID: 28122643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers. Saliva proteomics is a promising tool to study Sjögren syndrome.
    Tzioufas AG; Kapsogeorgou EK
    Nat Rev Rheumatol; 2015 Apr; 11(4):202-3. PubMed ID: 25668140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary gland secretome: a novel tool towards molecular stratification of patients with primary Sjögren's syndrome and non-autoimmune sicca.
    Blokland SLM; Hillen MR; van Vliet-Moret FM; Bikker A; de Jager W; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
    RMD Open; 2019; 5(1):e000772. PubMed ID: 30713719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of thymic stromal lymphopoietin in salivary glands of patients with primary Sjögren's syndrome is associated with increased disease activity.
    Hillen MR; Kruize AA; Bikker A; Wenting-van Wijk M; Radstake TR; Hack CE; Lafeber FP; van Roon JA
    Mod Rheumatol; 2016; 26(1):105-9. PubMed ID: 25995032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updates on Sjögren's syndrome: from proteomics to protein biomarkers.
    Baldini C; Cecchettini A; Gallo A; Bombardieri S
    Expert Rev Proteomics; 2017 Jun; 14(6):491-498. PubMed ID: 28532233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease.
    Ferraccioli G; De Santis M; Peluso G; Inzitari R; Fanali C; Bosello SL; Iavarone F; Castagnola M
    Autoimmun Rev; 2010 Jul; 9(9):622-6. PubMed ID: 20462525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7-H4 deficiency in salivary gland of patients with primary Sjögren's syndrome impairs the regulatory effect on T cells.
    Li X; Yu D; Yu N; Wang X; Li X; Harris DCH; Wang Y
    Int J Rheum Dis; 2017 Apr; 20(4):474-480. PubMed ID: 28217953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody synthesis in salivary glands of Sjögren's syndrome patients.
    Horsfall AC; Rose LM; Maini RN
    J Autoimmun; 1989 Aug; 2(4):559-68. PubMed ID: 2789658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome?
    Baldini C; Giusti L; Bazzichi L; Lucacchini A; Bombardieri S
    Autoimmun Rev; 2008 Jan; 7(3):185-91. PubMed ID: 18190876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of salivary aquaporin-5 in Sjögren's syndrome.
    Steinfeld SD; Delporte C
    Lancet; 2002 May; 359(9319):1777-8; author reply 1778. PubMed ID: 12049892
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sjögren's syndrome].
    Tylczyński W
    Otolaryngol Pol; 1977; 31(3):369-80. PubMed ID: 331194
    [No Abstract]   [Full Text] [Related]  

  • 19. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
    Soyfoo MS; Chivasso C; Perret J; Delporte C
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sjögren's syndrome (SS), a review of the subject and saliva as a diagnostic method].
    Riega-Torres JC; Villarreal-Gonzalez AJ; Ceceñas-Falcon LÁ; Salas-Alanis JC
    Gac Med Mex; 2016; 152(3):371-80. PubMed ID: 27335194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.